REQUEST A DEMO
Total
USD $0.00
Search more companies

Innventa Pharm D.O.O. (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Innventa Pharm D.O.O. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

innventa pharm ltd is a pharmaceutical company. The company offers a range of pharmaceutical solutions, including products for inflammation processes, ORL products, and a new portfolio of products. They have expanded their scope to other parts of the Republic of Srpska and to the Federation of Bosnia and Herzegovina, and claim to be present in the markets of Bosnia and Herzegovina, Montenegro, and Albania.

Headquarters
Sumatovacka 36
Belgrade; Belgrade; Postal Code: www.innventa-pharm.com

Contact Details: Purchase the Innventa Pharm D.O.O. report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Innventa Pharm D.O.O. report to view the information.
Outstanding Shares:
Purchase the Innventa Pharm D.O.O. report to view the information.
Registered Capital:
Purchase the Innventa Pharm D.O.O. report to view the information.
Incorporation Date:
2011
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Innventa Pharm D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
9.76%
Total operating revenue
12.97%
Operating profit (EBIT)
-9.06%
EBITDA
-2.79%
Net Profit (Loss) for the Period
43.23%
Total assets
6.78%
Total equity
8.72%
Operating Profit Margin (ROS)
-1.19%
Net Profit Margin
0.64%
Return on Equity (ROE)
1.93%
Debt to Equity Ratio
0.21%
Quick Ratio
0.68%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?